Immunglobulinfusionsproteine
European patent · EP2662449 · In force
Register entry
- Publication number
- EP2662449
- Application number
- EP12198380
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 30, 2008
- Published
- Nov 13, 2013
- Granted
- Feb 15, 2017
- Protection ends at the latest
- May 29, 2028
- Next annual fee due
- May 31, 2027
- IPC classes
- C12N 15/62 (2006.01)C07K 19/00 (2006.01)C07K 16/46 (2006.01)A61K 38/16 (2006.01)A61K 38/00 (2006.01)
- Priority
- US 940753 P 30.05.2007
- Divided from
- EP08766022
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 1, 2026
Change
Published in Swissreg on 01.06.2026
- Jun 1, 2025
Change
Published in Swissreg on 01.06.2025
- Jun 2, 2024
Change
Published in Swissreg on 02.06.2024
- Nov 2, 2023
Address changed
- Representative
- Frei Patentanwaltsbüro AG, Postfach, 8032 Zürich → Frei Patentanwaltsbüro AG, Hagenholzstrasse 85, 8050 Zürich
Published in Swissreg on 02.11.2023
- Jun 1, 2023
Change
Published in Swissreg on 01.06.2023
- Nov 7, 2018
Address changed
- Representative
- Frei Patentanwaltsbüro AG, Postfach 1771, 8032 Zürich → Frei Patentanwaltsbüro AG, Postfach, 8032 Zürich
Published in Swissreg on 07.11.2018
- Apr 27, 2017
Agent entered
- Representative
- Frei Patentanwaltsbüro AG, Postfach 1771, 8032 Zürich
Published in Swissreg on 27.04.2017
- Feb 15, 2017
Granted
Published in Swissreg on 15.02.2017
Parties
Holder
Inventor
Sung, Young Chul
Seoul, KR
Yang, Sehwan
Seongnam-si, Gyeonggi-do, KR
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.